lenalidomid zentiva 15 mg
zentiva k.s. - lenalidomid - kapsel, hard - 15 mg
lenalidomid zentiva 25 mg
zentiva k.s. - lenalidomid - kapsel, hard - 25 mg
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
advantage vet 100 mg/ ml
bayer animal health gmbh - imidakloprid - påflekkingsvæske, oppløsning - 100 mg/ ml
advantage vet 100 mg/ ml
bayer animal health gmbh - imidakloprid - påflekkingsvæske, oppløsning - 100 mg/ ml
copegus 200 mg
orifarm as - ribavirin - tablett, filmdrasjert - 200 mg
copegus 200 mg
orifarm as - ribavirin - tablett, filmdrasjert - 200 mg
copegus 400 mg
orifarm as - ribavirin - tablett, filmdrasjert - 400 mg
aloxi
helsinn birex pharmaceuticals ltd. - palonosetron hydroklorid - vomiting; cancer - antiemetika og antinauseants, , serotonin (5ht3) antagonister - aloxi er indisert hos voksne:forebygging av akutt kvalme og oppkast forbundet med svært emetogenic kreft, kjemoterapi,forebygging av kvalme og oppkast forbundet med moderat emetogenic kreft kjemoterapi. aloxi er angitt i paediatric pasienter 1 måneders alder og voksne:forebygging av akutt kvalme og oppkast forbundet med svært emetogenic kreft kjemoterapi og forebygging av kvalme og oppkast forbundet med moderat emetogenic kreft kjemoterapi.
viread 245 mg
2care4 - tenofovirdisoproksilfumarat - tablett, filmdrasjert - 245 mg